Journal article icon

Journal article

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.

Publication status:
Published

Actions


Access Document


Publisher copy:
10.1136/ard.58.2008.i56

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
Paleolog, E More by this author
Charles, P More by this author
Ballara, S More by this author
Expand authors...
Journal:
Annals of the rheumatic diseases
Volume:
58 Suppl 1
Issue:
SUPPL. 1
Pages:
I56-I60
Publication date:
1999-11-05
DOI:
EISSN:
1468-2060
ISSN:
0003-4967
URN:
uuid:97e3baee-3ef0-4121-8819-bc6677e47bed
Source identifiers:
377339
Local pid:
pubs:377339

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP